Funding Stories
Meet the competition: AltCap Your Biz unveils finalists for pitch event, $60K in awards
A popular fall pitch competition for emerging entrepreneurs is returning to Union Station in November with AltCap today announcing 10 finalists for $60,000 in cash prizes — ranging from Kansas City’s first mobile matcha cart to specialty wellness retailers and a dog toy innovator. “The AltCap Your Biz Pitch Competition is so much more than…
‘The American dream is the Midwest’: LaunchKC powers next generation of startup job creators
Editor’s note: The following is part of an ongoing feature series exploring impacts of initiatives within the Economic Development Corporation of Kansas City through a paid partnership with EDCKC. Relocating to Kansas City after winning a LaunchKC grant — and the community and infrastructure support that comes with it — gives Russel Karim’s startup a centralized…
Trially secures $4.7M seed round, launches ‘Margo’ AI solution to clear patient bottleneck
A Kansas City startup’s AI-first platform is expected to save time — and patient lives — thanks to a successful seed round for its clinical trial recruitment tech, explained Kyle McAllister, noting his startup’s solution could help speed up access to treatment by years. Trially, one of Startland News’ 10 Kansas City Startups to Watch in…
KC startups graduate K-State accelerator, earning equity-free cash, greater conviction
A trio of Kansas City-built ventures — from sports apparel and mental health solutions for young athletes to tech that uses autonomous drones and 3D vision AI — were among the Kansas businesses earning funding through an eight-week accelerator at Kansas State University. The Center for Entrepreneurship Accelerator program at K-State — which provides participants…
LPOXY initiates $28M Series A financing with 5 Horizons Ventures to fund pivotal trial
PLATTE CITY, Mo. — Funding to secure the upcoming trial of a Missouri biopharmaceutical company’s solution for preventing a deadly gut infection could prove critical in the fight against a condition that claims 80 U.S. lives daily, said Dr. Larry Sutton. LPOXY Therapeutics, which is developing a novel non-antibiotic therapy to prevent Clostridioides difficile infections…
